Victory Capital Management’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.6K | Sell |
|
|||||
|
2025
Q1 | $16.8K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $329K | Sell |
|
|||||
|
2021
Q3 | $614K | Buy |
|
|||||
|
2021
Q2 | $313K | Buy |
|
|||||
|
2021
Q1 | $204K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $14K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $7K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $612K | Buy |
|
|||||
|
2018
Q4 | $534K | Sell |
|
|||||
|
2018
Q3 | $1.07M | Sell |
|
|||||
|
2018
Q2 | $1.54M | Sell |
|
|||||
|
2018
Q1 | $1.43M | Buy |
|
|||||
|
2017
Q4 | $1.81M | Buy |
|
|||||
|
2017
Q3 | $1.53M | Buy |
|
|||||
|
2017
Q2 | $1.11M | Sell |
|
|||||
|
2017
Q1 | $1.24M | Sell |
|
|||||
|
2016
Q4 | $1.52M | Buy |
|